Company News

ProMIS Neurosciences Announces Trading on OTCQB Venture Market

By | News

ProMIS Neurosciences Announces Trading on OTCQB Venture Market TORONTO, Ontario and CAMBRIDGE, Massachusetts, December 4, 2017 – ProMIS Neurosciences, Inc., a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced that its common shares have been approved for trading on the OTCQB® Venture Market (OTCQB) in…

Read More

ProMIS Neurosciences Announces Third Quarter 2017 Results

By | News

ProMIS™ Neurosciences, Inc. NEWS RELEASE TSX: PMN FOR IMMEDIATE RELEASE ProMIS Neurosciences Announces Third Quarter 2017 Results TORONTO, Ontario and CAMBRIDGE, Massachusetts November 13, 2017 – ProMIS Neurosciences, Inc., a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced its operational and financial results for the…

Read More